Steve joined the Sanger Institute in 1993 after gaining a PhD in molecular immunology. He left to pursue a career in industry with a university spin out which grew to become a global PLC. His journey into digital health began in 2008 during which he gained an in-depth understanding of the diverse players and their interactions within this challenging market. He has advised a diverse range of organisations on many aspects of digital health and is a regular speaker and author on the subject. Specialisms: Strategy, market dynamics, economic development
The UK Market
Healthcare is dominated by public sector service providers in the form of the NHS and local authorities. The telecare sector has grown significantly in the UK but has recently become staid awaiting a next generation of offerings. Adoption of digital health technology outside of telecare has been modest to date, however, the rate is set to increase but in the context of a highly politicised environment and budgetary constraints. Retail outlets in the form of pharmacy chains and consumer electronics outlets are increasingly active in the digital health space and further opportunity will be presented by the supermarket chains. Pharma and Medtech are associated with a strong life science base in the UK and demonstrate increasing activity in digital health along with a growing interest from health insurance providers.